Cartesian Therapeutics Inc.
Organization details
- Legal name
- Cartesian Therapeutics Inc.
- Former names
- Selecta Biosciences Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Frederick
- Headquarters state / province
- Maryland
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- RNAC
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001453687
- Wikidata ID
- Q30288672
Board of directors
-
Adrian Ion Bot · DirectorSince 2025
-
Aymeric Sallin · DirectorSince 2023
-
Carrie Smith Cox · DirectorSince 2023
-
Carsten Brunn · Director · President and CEOSince 2023
-
Goran Ando · DirectorSince 2023
-
Kemal Malik · DirectorSince 2024
-
Michael Singer · DirectorSince 2023
-
Murat Kalayoglu · DirectorSince 2023
-
Nishan M. DeSilva · DirectorSince 2023
-
Patrick J. Zenner · DirectorSince 2023
-
Scott Dunseth Myers · DirectorSince 2023
-
Timothy A. Springer · DirectorSince 2023
-
Timothy C. Barabe · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 12, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
59.2%
-
61.4%
-
94.1%
Board connections
5 of this board's directors also sit on 8 other boards. 6 are in the same sector.
- via Goran Ando
-
Heartflow Inc. Same sectorvia Timothy C. Barabe
-
Organon & Co. Same sectorvia Carrie Smith Cox
-
Solventum Corporation Same sectorvia Carrie Smith Cox
-
Tectonic Therapeutic Inc. Same sectorvia Timothy A. Springer
- via Carrie Smith Cox
-
Viridian Therapeutics Inc. Same sectorvia Scott Dunseth Myers
-
Zentalis Pharmaceuticals Inc. Same sectorvia Scott Dunseth Myers
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $205,800
- 1 purchase by 1 insider
- Sold, last 12 months
- $258,683
- 3 sales by 3 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 2, 2026 | Hoge Elizabeth 10% owner | Option exercise | +758,001 | — | — |
| Apr 2, 2026 | Murat Kalayoglu 10% owner | Option exercise | +758,001 | — | — |
| Mar 13, 2026 | Michael Singer Director | Gift | −6,555 | — | — |
| Jan 6, 2026 | Carsten Brunn Director, Officer (President and CEO) | Open-market sale | −23,766 | $6.82 | $162,084 |
| Jan 6, 2026 | Miljkovic Milos Officer (Chief Medical Officer) | Open-market sale | −3,573 | $6.82 | $24,368 |
| Jan 6, 2026 | Davis Blaine Officer (Chief Financial Officer) | Open-market sale | −10,591 | $6.82 | $72,231 |
| Jan 2, 2026 | Nishan M. DeSilva Director | Grant or award | +2,600 | — | — |
| Jan 2, 2026 | Carsten Brunn Director, Officer (President and CEO) | Grant or award | +143,200 | — | — |
| Jan 2, 2026 | Kemal Malik Director | Grant or award | +2,600 | — | — |
| Jan 2, 2026 | Miljkovic Milos Officer (Chief Medical Officer) | Grant or award | +27,000 | — | — |
| Jan 2, 2026 | Patrick J. Zenner Director | Grant or award | +2,600 | — | — |
| Jan 2, 2026 | Seymour June Ann Officer (Chief Accounting Officer) | Grant or award | +6,500 | — | — |
| Jan 2, 2026 | Davis Blaine Officer (Chief Financial Officer) | Grant or award | +37,000 | — | — |
| Jan 2, 2026 | Timothy C. Barabe Director | Grant or award | +2,600 | — | — |
| Jan 2, 2026 | English Emily Officer (Chief Operations Officer) | Grant or award | +24,000 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Cartesian Therapeutics Inc.
Who is the CEO of Cartesian Therapeutics Inc.?
Carsten Brunn is Cartesian Therapeutics Inc.'s President and CEO.
How many directors are on Cartesian Therapeutics Inc.'s board?
Cartesian Therapeutics Inc.'s board has 13 directors: Adrian Ion Bot, Aymeric Sallin, Carrie Smith Cox, Carsten Brunn, Goran Ando, Kemal Malik, Michael Singer, Murat Kalayoglu, Nishan M. DeSilva, Patrick J. Zenner and 3 others.
Are Cartesian Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, Cartesian Therapeutics Inc. insiders bought $205,800 of shares in 1 purchase and sold $258,683 of shares in 3 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="cartesian-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.